Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Randomized Comparison Clinical Trial of Target Activated CIK for Advanced Liver Cancer

NCT03146637 is registered in ClinicalTrials.gov with Benhealth Biopharmaceutical (Shenzhen) Co., Ltd. as lead sponsor.

NCT NCT03146637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03146637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Randomized Comparison Clinical Trial of Target Activated CIK for Advanced Liver Cancer
Lead sponsor
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.
Phase
Phase 2
Overall status
Unknown status
Start date
May 1, 2017
Completion date
January 28, 2021
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced liver cancer